My name is Joe Polidor and I too, am taking Neurontin. In fact I am =
taking 1200 mg a day. The purpose is to help me sleep. It does seem to =
help me with my sleep problems. The only side effect I've noted, is =
being somewhat groggy in the morning.
----------
From: Ellen Hertz[SMTP:eshertz(AT)access.digex.net]
Sent: Tuesday, December 23, 1997 7:07 PM
To: tmic-list(AT)eskimo.com
Subject: Re: Neurontin
At 04:10 PM 12/23/97 -0800, you wrote:
>Ellen Hertz wrote:
>>=20
>> Hi all,
>>=20
>> My neurologist recently prescribed neurontin. It is relieving the =
tingling
>> and I want to keep taking it. However, the literature that came with =
it
>> worried me because it listed visual disturbances as a possible side =
effect.
>> I would appreciate hearing from anybody who is taking it.
>>=20
>> Thanks.
>> Ellen
>Hi Ellen,
>I'm Diana and I've been taking Neurontin since July '97. I'm taking
>600 milligrams three times daily. It not only helped the tingling
>but my mobility was greatly improved after the Dr increased the
>dosage. It also has helped the pain. The only side effects have
>been by memory has been impaired (sometimes this can be an asset).
>My Neurologist indicated I may have drowsiness, dizziness, blurred
>vision but only in the beginning although I did not experience any
>of these as I started with a low dosage and increased gradually.
>Hope this helps.
>Diana in Albany,NY
>
Diana,
It certainly does. Thanks.
Ellen
------ =_NextPart_000_01BD1613.6F9705C0
Content-Type: application/ms-tnef
Content-Transfer-Encoding: base64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------ =_NextPart_000_01BD1613.6F9705C0--